Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Change in Inventory (2016 - 2025)

Iradimed (IRMD) has disclosed Change in Inventory for 13 consecutive years, with $559684.0 as the latest value for Q3 2025.

  • On a quarterly basis, Change in Inventory rose 180.01% to $559684.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$416927.0, a 802.25% decrease, with the full-year FY2024 number at -$3.1 million, down 141.86% from a year prior.
  • Change in Inventory was $559684.0 for Q3 2025 at Iradimed, down from $751217.0 in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $3.0 million in Q2 2023 to a low of -$1.8 million in Q4 2024.
  • A 5-year average of $393437.2 and a median of $316290.0 in 2022 define the central range for Change in Inventory.
  • Peak YoY movement for Change in Inventory: skyrocketed 1527.3% in 2023, then plummeted 238.15% in 2024.
  • Iradimed's Change in Inventory stood at $48595.0 in 2021, then skyrocketed by 733.76% to $405164.0 in 2022, then surged by 230.13% to $1.3 million in 2023, then tumbled by 238.15% to -$1.8 million in 2024, then surged by 130.29% to $559684.0 in 2025.
  • Per Business Quant, the three most recent readings for IRMD's Change in Inventory are $559684.0 (Q3 2025), $751217.0 (Q2 2025), and $120010.0 (Q1 2025).